Taiwan · Delayed Price · Currency is TWD Alar Pharmaceuticals Statistics
Total Valuation
TPEX:6785 has a market cap or net worth of TWD 6.71 billion. The enterprise value is 4.43 billion.
| Market Cap | 6.71B |
| Enterprise Value | 4.43B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Aug 25, 2026 |
Share Statistics
TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 1.91% in one year.
| Current Share Class | 66.80M |
| Shares Outstanding | 66.80M |
| Shares Change (YoY) | +1.91% |
| Shares Change (QoQ) | +1.41% |
| Owned by Insiders (%) | 24.57% |
| Owned by Institutions (%) | 7.63% |
| Float | 40.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,237.80 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.77, with a Debt / Equity ratio of 0.00.
| Current Ratio | 38.77 |
| Quick Ratio | 38.22 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -2,088.44 |
Financial Efficiency
Return on equity (ROE) is -2.99% and return on invested capital (ROIC) is -212.51%.
| Return on Equity (ROE) | -2.99% |
| Return on Assets (ROA) | -4.30% |
| Return on Invested Capital (ROIC) | -212.51% |
| Return on Capital Employed (ROCE) | -7.17% |
| Weighted Average Cost of Capital (WACC) | 4.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 32 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6785 has paid 19.62 million in taxes.
| Income Tax | 19.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.22% in the last 52 weeks. The beta is 0.12, so TPEX:6785's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -43.22% |
| 50-Day Moving Average | 110.79 |
| 200-Day Moving Average | 191.76 |
| Relative Strength Index (RSI) | 42.21 |
| Average Volume (20 Days) | 62,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6785 had revenue of TWD 3.00 million and -72.13 million in losses. Loss per share was -1.07.
| Revenue | 3.00M |
| Gross Profit | 2.59M |
| Operating Income | -171.25M |
| Pretax Income | -52.51M |
| Net Income | -72.13M |
| EBITDA | -167.45M |
| EBIT | -171.25M |
| Loss Per Share | -1.07 |
Balance Sheet
The company has 2.28 billion in cash and 1.85 million in debt, with a net cash position of 2.28 billion or 34.18 per share.
| Cash & Cash Equivalents | 2.28B |
| Total Debt | 1.85M |
| Net Cash | 2.28B |
| Net Cash Per Share | 34.18 |
| Equity (Book Value) | 2.38B |
| Book Value Per Share | 35.09 |
| Working Capital | 2.26B |
Cash Flow
In the last 12 months, operating cash flow was -186.65 million and capital expenditures -2.98 million, giving a free cash flow of -189.63 million.
| Operating Cash Flow | -186.65M |
| Capital Expenditures | -2.98M |
| Depreciation & Amortization | 3.81M |
| Net Borrowing | -3.41M |
| Free Cash Flow | -189.63M |
| FCF Per Share | -2.84 |
Margins
| Gross Margin | 86.40% |
| Operating Margin | -5,708.40% |
| Pretax Margin | -1,750.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.91% |
| Shareholder Yield | -1.81% |
| Earnings Yield | -1.07% |
| FCF Yield | -2.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6785 has an Altman Z-Score of 114.81 and a Piotroski F-Score of 2.
| Altman Z-Score | 114.81 |
| Piotroski F-Score | 2 |